Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;26(8):542–549. [Article in Spanish] doi: 10.1016/S0212-6567(00)78719-1

Validez y fiabilidad del instrumento «FANTASTIC» para medir el estilo de vida en pacientes mexicanos con hipertensión arterial

Validity and reliability of the «fantastic» instrument for measuring life-style in mexican patients with hypertension

JM López-Carmona a, R Rodríguez-Moctezuma b,*, C Munguía-Miranda c, JL Hernández-Santiago d, E Casas de la Torre e
PMCID: PMC7679574  PMID: 11149187

Abstract

Objective

To evaluate the reliability and validity of the instrument «FANTASTIC», when being applied to a sample of Mexican patients with high blood pressure.

Design

Observational, prospective, longitudinal, descriptive.

Setting

Unit of Family Medicine N.° 91 Instituto Mexicano del Seguro Social.

Patients

103 patients with hypertension on treatment, adults, non diabetics that knew to read and to write.

Interventions

Was applied «FANTASTIC» instrument (that consists of 25 closed items on the lifestyle), translated to Spanish in versions of 3 and 5 answers, with an interval test-retest of 14 to 21 days. The average of the systolic arterial tension (SAT), diastolic (DAT) and half arterial tension (HAT) was calculated of the last 3 registrations of the clinical file, mass corporal index (MCI), waist/hip ratio (WHR), and fast glucaemia (FG) was measured.

Measurement and results

66% was women. The correlation test-retest, in the version of five answer options was of 0.81 (p = 0.01) and among both versions of 0.91 (p = 0.01). They were not differences in the total qualification according to the sex. To more age, it was bigger qualification and smaller MCI and FG.Weak correlation was observed (not significant) among more total qualification and smaller DAT. There was negative correlation among more qualification in the nutrition domain and smaller MCI (p = 0.01), among more qualification in the domain of tobacco (smaller consumption) with smaller DAT (p = 0.05) and smaller HAT (p = 0.05).

Conclusions

The consistency of the instrument is very good. Their content doesn't correlate specifically with the control indicators in hypertension.

Bibliografía

  • 1.The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446. doi: 10.1001/archinte.157.21.2413. [DOI] [PubMed] [Google Scholar]
  • 2.Asociación Nacional de Cardiólogos de México, Sociedad Mexicana de Cardiología, Sociedad Mexicana para el Estudio de la Hipertensión Arterial Primer Consenso Nacional de Hipertensión Arterial. Rev Mex Cardiol. 1995;6(Supl):9–14. [Google Scholar]
  • 3.Dirección General de Estadística, Informática y Evaluación, SSA . Dirección General de Estadística, Informática y Evaluación, SSA. Serie monográfica; México:: 1993. Enfermedades crónicas, perfiles estadísticos. [Google Scholar]
  • 4.Fletcher A.E., Bulpitt C.J. Epidemiological aspect of cardiovascular disease in the elderly. J Hypertension. 1992;10(Supl 2):51–58. [PubMed] [Google Scholar]
  • 5.Frohlich E. Hipertensión. Compendio de cardiología preventiva. American Heart Association, 1994:131. [Google Scholar]
  • 6.Kannel W.B. Blood pressure as a cardiovascular risk factor. JAMA. 1996;275(24):1571–1576. [PubMed] [Google Scholar]
  • 7.Bustamante M.L., Borja A.V., Escamilla C.J. El estudio de causa múltiple de muerte en las enfermedades cardio y cerebrovasculares. Arch Inst Cardiol Méx. 1991;61:261–266. [PubMed] [Google Scholar]
  • 8.Camacho-Hernández R., Corona-Muñiz I., Vázquez-Martínez J.L., Martínez-Rodríguez F. Escobedo-de la Peña J. Factores de riesgo para cardiopatía isquémica en México: un estudio de casos clínicos y testigos. Arch Inst Cardiol Méx. 1995;65:315–322. [PubMed] [Google Scholar]
  • 9.Rodríguez S.J., Chávez D.R., Marmolejo H.R., Reynoso M.M. Epidemiología de la hipertensión arterial en México. Aspectos históricos. Med Int Mex. 1997;13:283–288. [Google Scholar]
  • 10.Sepúlveda, Rull J. Encuesta Nacional de Enfermedades Crónicas. México: Dirección General de Epidemiología. Instituto Nacional de la Nutrición Salvador Zubirán. 1993 [Google Scholar]
  • 11.Hipertensión Arterial Guía diagnóstico terapéutica. Rev Med IMSS (Méx) 1997;35:411–430. [Google Scholar]
  • 12.Otero F., Fierro H., Peña G., Rodríguez A. La hipertensión arterial en el Instituto Mexicano del Seguro Social. Med Int Mex. 1995;11:15–20. [Google Scholar]
  • 13.Rubio G.A., Lozano N.J., Vargas A.G., Rodríguez L.L., Sánchez G.A. Aspectos recientes en la fisiopatología de la hipertensión arterial. Med Int Mex. 1997;13:294–300. [Google Scholar]
  • 14.The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. Arch Intern Med. 1997;157:657–667. [PubMed] [Google Scholar]
  • 15.The Trials of Hypertension Prevention (TOHP) Collaborative Research Group Design of a multicenter trials to evaluate long-term lifestyle intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (Phase II) Ann Epidemiol. 1995;5:130–139. doi: 10.1016/1047-2797(94)00057-z. [DOI] [PubMed] [Google Scholar]
  • 16.The Trials of Hypertension Prevention Collaborative Research Group The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213–1220. doi: 10.1001/jama.1992.03480090061028. [DOI] [PubMed] [Google Scholar]
  • 17.Whelton P.K., Appel L.J., Espeland M.A., Applegate W.B., Ettinger W.H., Kostis J.B. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE) JAMA. 1996;279:839–846. doi: 10.1001/jama.279.11.839. [DOI] [PubMed] [Google Scholar]
  • 18.Midgley J.P., Matthew A.G., Greenwood C.M., Logan A.G. Effect of a reduced dietary sodium on blood pressure. A metaanalysis of randomized controlled trials. JAMA. 1996;275:1590–1597. doi: 10.1001/jama.1996.03530440070039. [DOI] [PubMed] [Google Scholar]
  • 19.Wilson D.M., Ciliska D. Lifestyle assessment: development and use of the FANTASTIC Checklist. Can Fam Physician. 1984;30:1527–1532. [Google Scholar]
  • 20.Wilson D.M., Ciliska D. Lifestyle assessment: helping patients change health behaviors. Can Fam Physician. 1984;30:1665–1670. [Google Scholar]
  • 21.Wilson D.M., Ciliska D. Lifestyle assessment: testing the FANTASTIC Instrument. Can Fam Physician. 1984;30:1863–1866. [Google Scholar]
  • 22.Sharratt J.K., Sharratt M.T., Smith D.M., Howell M.J., Davenport L. FANTASTIC Lifestyle Survey Of University of Waterloo Employees. Can Fam Physician. 1984;30:1869–1872. [PMC free article] [PubMed] [Google Scholar]
  • 23.Kason Y., Ylanko V. FANTASTIC Lifestyle assessment: Part 5. Measuring lifestyle in family practice. Can Fam Physician. 1984;30:2379–2383. [PMC free article] [PubMed] [Google Scholar]
  • 24.Kamien M., Power R. Lifestyle and health habits of fourth year medical students a University of Western Australia. Aust Fam Physician. 1996;(Supl I):26–29. [PubMed] [Google Scholar]
  • 25.Cummings S.R., Strull W., NevittMC, Hulley S.B. Planificación de las mediciones: cuestionarios. In: Hulley S.B., Cummings S.R., editors. Diseño de la investigación clínica. Un enfoque epidemiológico. Doyma; Barcelona:: 1993. pp. 47–58. [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES